-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
UNITED THERAPEUTICS Corp quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q2 2019 to Q3 2025.
- UNITED THERAPEUTICS Corp Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was $339M, a 9.58% increase year-over-year.
- UNITED THERAPEUTICS Corp Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was $1.27B, a 14.5% increase year-over-year.
- UNITED THERAPEUTICS Corp annual Net Income (Loss) Attributable to Parent for 2024 was $1.2B, a 21.4% increase from 2023.
- UNITED THERAPEUTICS Corp annual Net Income (Loss) Attributable to Parent for 2023 was $985M, a 35.4% increase from 2022.
- UNITED THERAPEUTICS Corp annual Net Income (Loss) Attributable to Parent for 2022 was $727M, a 52.9% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)